Suchergebnisse - "Mita, Koji"

PubPharm (107)

1

Fourth national Japanese antimicrobial susceptibility pattern surveillance program : Bacterial isolates from patients with complicated urinary tract infections

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2024

von Kobayashi, K. | Takahashi, S. | Yasuda, M. | +46

2

Risk classification system using the detailed positive surgical margin status for predicting biochemical recurrence after robot-assisted radical prostatectomy

enthalten in: Asia-Pacific journal of clinical oncology | 2024

von Hatayama, T. | Goto, K. | Fujiyama, K. | +3

3

Enzalutamide versus Abiraterone Plus Prednisolone for Nonmetastatic Castration-Resistant Prostate Cancer : A Sub-Analysis from the ENABLE Study for PCa

enthalten in: Cancers | 2024

von Mita, K. | Izumi, K. | Goriki, A. | +19

4

Clinical factors for tumor response, progression, and survival in nivolumab for advanced renal cell carcinoma in the SNiP-RCC study

enthalten in: International journal of urology : official journal of the Japanese Urological Association | 2023

von Blas, L. | Shiota, M. | Miyake, H. | +25

CommentIn: Int J Urol. 2023 Sep;30(9):796-797. - PMID 37563930

5

Effect of genetic polymorphisms on outcomes following nivolumab for advanced renal cell carcinoma in the SNiP-RCC trial

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Shiota, M. | Miyake, H. | Takahashi, M. | +24

6

Impact of low and high body mass index on predicting therapeutic efficacy and prognosis in patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors

enthalten in: International journal of urology : official journal of the Japanese Urological Association | 2023

von Takemoto, K. | Sekino, Y. | Kitano, H. | +13

7

Significance of timing of therapeutic line on effectiveness of nivolumab for metastatic renal cell carcinoma

enthalten in: Current urology | 2023

von Teishima, J. | Murata, D. | Yukihiro, K. | +12

8

Impact of low and high body mass index on predicting therapeutic efficacy and prognosis in patients with metastatic renal cell carcinoma treated with first‐line tyrosine kinase inhibitors

enthalten in: International Journal of Urology | 2023

von Takemoto, K. | Sekino, Y. | Kitano, H. | +13

9

Impact of modified Glasgow prognostic score on predicting prognosis and modification of risk model for patients with metastatic renal cell carcinoma treated with first line tyrosine kinase inhibitor

enthalten in: Urologic oncology | 2022

von Yukihiro, K. | Teishima, J. | Goto, K. | +12

10

The effect of aging on the repeated-dose liver micronucleus assay using diethylnitrosamine

enthalten in: Genes and environment : the official journal of the Japanese Environmental Mutagen Society | 2022

von Satomoto, K. | Suzuki, I. | Mita, K. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]